The report provides a detailed analysis essential for establishing a Vinorelbine production plant. It encompasses all critical aspects necessary for Vinorelbine production, including the cost of Vinorelbine production, Vinorelbine plant cost, Vinorelbine production costs, and the overall Vinorelbine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Vinorelbine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Vinorelbine is a chemotherapy drug that is used to cure non-small cell lung cancer (NSCLC) and metastatic breast cancer. It works by interfering with the action of microtubules, inhibiting cell division, and slowing or stopping cancer growth. It is given intravenously or orally and used in combination with other chemotherapy, like cisplatin, to increase its effectiveness. Its primary indications are for treating advanced and metastatic NSCLC. Also, it is effective in treating aggressive fibromatosis and rhabdomyosarcoma in combination with other therapies for other malignancies. Its side effects include bone marrow suppression, nausea, vomiting, and peripheral neuropathy, while severe complications may include allergic reactions or respiratory problems.
The market for Vinorelbine is driven by several key factors. Its use in the treatment of breast cancer and non-small cell lung cancer contributes to its growing demand. The development in oncology and multidrug combinations improves its use in cancer therapy and makes it a preferred choice in clinical practice. Growing awareness regarding cancer treatment and enhanced access to healthcare services further contributes to its demand. As a result of regulatory support and approvals on new uses or formulations of Vinorelbine, which come together well for effective treatments reaching patients faster, its market is given an extra boost. Overall, industrial Vinorelbine procurement is influenced by its usage in treating breast cancer and non-small cell lung cancer, along with improved access to healthcare and regulatory support for new formulations.
Raw Material for Vinorelbine Production
According to the Vinorelbine production plant project report, the key raw materials used in the production of Vinorelbine include Catharanthus Roseus-Reagents-Solvents.
Production Process of Vinorelbine
The extensive Vinorelbine production cost report consists of the following major industrial production process:
- From Catharanthus Roseus, Reagents and Solvents: The production of Vinorelbine consists of several steps. First, Catharanthus roseus extract is obtained and goes through alkylation reactions, forming an intermediate compound. This intermediate compound is cyclized to form the core structure of Vinorelbine. After that, the compound is functionalized to get the final compound. Finally, the crude product is purified by crystallization or chromatography to obtain pure Vinorelbine.
Vinorelbine is a semi-synthetic vinca alkaloid with a molecular formula C45H54N4O8 and a molecular weight of around 778.947 g/mol. It appears as a clear, colorless, light yellow solution that is stored in temperatures between 2-8°C. Its terminal elimination half-life is more than 40 hours, and high clearance rates range from 0.97 to 1.26 L/h/kg. Less than 20% of the administered dose is excreted unchanged in urine, while a significant portion is eliminated via bile and feces. It has variable bioavailability from approximately 12% to 59%, averaging around 27%. Its side effects include bone marrow suppression, that leads to neutropenia and anemia.
